10X Genomics Inc Class A (TXG)
EBITDA Growth
197.73%
TTM · Period ending:
TXG EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported197.73%period ending
Latest reported197.73%period ending
TXG TTM EBITDA YoY % (79.80% → 197.73%)
Year-over-year change
High-resolution chart · PNG
TXG ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 197.7298% | |
| 183.7733% | |
| 152.6502% | |
| 76.4925% | |
| 79.4649% | |
| 47.0665% | |
| 34.6754% | |
| 26.39% | |
| -44.9098% | |
| -54.8004% | |
| -59.6331% | |
| -37.8805% | |
| -21.6473% | |
| -152.8265% | |
| -422.4192% | |
| 69.1845% | |
| 77.3394% | |
| 89.2969% | |
| 95.2129% | |
| -267.3408% | |
| -671.173% | |
| -1,292.3904% | |
| -2,231.9399% | |
| -21.8236% | |
| 39.9484% | |
| 62.3111% | |
| 79.8024% |